8-K

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                              --------------------

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (Date of earliest event reported): February 28, 2007


                              IMMERSION CORPORATION
             (Exact name of registrant as specified in its charter)

                              --------------------


            Delaware                  000-27969                94-3180138
 ----------------------------  ------------------------   ----------------------
 (State or other jurisdiction  (Commission File Number)       (IRS Employer
       of incorporation)                                    Identification No.)

                              --------------------

                                  801 Fox Lane
                           San Jose, California 95131
               (Address of principal executive offices) (Zip Code)

                              --------------------

       Registrant's telephone number, including area code: (408) 467-1900


                                 Not Applicable
          (Former name or former address, if changed since last report)



Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))




Item 5.02    Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

         (d) Anne DeGheest was elected to the Board of Directors of Immersion
Corporation, a Delaware corporation ("Immersion"), effective as of March 1,
2007. Ms. DeGheest was also elected to the Nominating and Corporate Governance
committee of Immersion's Board of Directors (the "Board"). Additionally, the
Board determined that Ms. DeGheest is to serve as a Class I director, and she
will stand for election at Immersion's 2009 annual meeting of stockholders.

         Ms. DeGheest has served as founder and a principal of MedStars, an
investment and executive management firm since August 1986. In November 1998,
Ms. DeGheest founded and served as president and chief executive officer of
medpool.com, Inc., an e-commerce hospital procurement company until September
2002 when medpool.com's assets were sold to BoldFish. From March through
November 1998, Ms. DeGheest was an entrepreneur in residence at Institutional
Venture Partners, a venture capital firm. From September 1979 through March
1997, Ms. DeGheest served in various sales and marketing roles at OmniCell
Technologies, Nellcor and Raychem. Ms. DeGheest holds an M.S. in general
engineering and business from the University of Brussels, Belgium and an M.B.A.
from Harvard University.

Item 5.03    Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
             Year

         (a) On February 28, 2007, the Board of Directors of Immersion adopted
resolutions pursuant to Section 2.1 of Immersion's Bylaws to fix the authorized
number of directors at seven (7). Immersion's Bylaws, as amended, are filed as
Exhibit 3.1 to Immersion's Annual Report on Form 10-K filed with the Commission
on March 28, 2003, which is incorporated herein by reference.

Item 9.01    Financial Statements and Exhibits.

         (d) Exhibits.

  Exhibit No.                         Description
  -----------                         -----------

     99.1      Press Release dated March 5, 2007 announcing the election of
               Anne DeGheest to the Board of Directors of Immersion Corporation.








         Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.

                             IMMERSION CORPORATION


Date:  March 5, 2007         By:  /s/ Stephen M. Ambler
                                 ---------------------------------------------
                                   Stephen M. Ambler
                                   Chief Financial Officer and Vice President,
                                   Finance






                                  EXHIBIT INDEX
                                  -------------


  Exhibit No.                         Description
  -----------                         -----------

     99.1      Press Release dated March 5, 2007 announcing the election of
               Anne DeGheest to the Board of Directors of Immersion Corporation.

EX-99.1

                                                                    Exhibit 99.1

          Anne DeGheest Joins Immersion's Board of Directors

         Brings Entrepreneurial and Medical Industry Expertise

    SAN JOSE, Calif.--(BUSINESS WIRE)--March 5, 2007--Immersion
Corporation (NASDAQ:IMMR), a leading developer and licensor of touch
feedback technology, today announced the appointment of Anne DeGheest
to its board of directors, effective March 1st.

    Ms. DeGheest has served since August 1986 as founder and principal
of MedStars, an investment and executive management firm specializing
in starting and developing new life sciences companies with innovative
products and services which included Pyxis, Aspect Medical Systems,
Visicu, Thermage and Pixel Optics. She also serves on the device
screening committee of Life Science Angels, Inc., an angel investment
group focused solely on biotechnology and medical device companies.
From March through November 1998, she was an entrepreneur in residence
at Institutional Venture Partners, a venture capital firm.

    From November 1998 to September 2002, Ms. DeGheest founded and
served as president and chief executive officer of medpool.com, Inc.,
an e-commerce hospital procurement company. Previously, DeGheest was
vice president of marketing at OmniCell Technologies, a leader in
automated point-of-use management systems for medical supplies, and
marketing director for Nellcor, a manufacturer of pulse oximetry and
critical care solutions. DeGheest also held a sales and marketing
management position in Raychem's Computer and Telecommunication
Division. She has a Masters of Science in general engineering and
business from the University of Brussels, Belgium and a Masters of
Business Administration from Harvard University.

    "Anne's experience will be a great asset to our medical training,
touchscreen, and mobile device product businesses," said Vic Viegas,
Immersion CEO. "Her background and skills will help Immersion broaden
market reach for our touch interface technologies."

    "I believe the medical industry can and will certainly benefit
from integrating Immersion TouchSense(R) technology," said DeGheest.
"The company is having success, and it seems the time has come for a
much wider adoption by the medical community of training simulators
with Immersion's touch feedback technology. I'm delighted to have the
opportunity to help make it happen."

    About Immersion (www.immersion.com)

    Founded in 1993, Immersion Corporation is a recognized leader in
developing, licensing, and marketing digital touch technology and
products. Using Immersion's advanced touch feedback technology
(www.immersion.com/corporate/products/), electronic user interfaces
can be made more productive, compelling, entertaining, or safer.
Immersion's technology is deployed across automotive, entertainment,
industrial controls, medical training, mobility, and three-dimensional
simulation markets. Immersion's patent portfolio includes over 600
issued or pending patents in the U.S. and other countries.

    Forward Looking Statements

    This press release contains "forward-looking statements" that
involve risks and uncertainties, as well as assumptions that, if they
never materialize or prove incorrect, could cause the results of
Immersion Corporation and its consolidated subsidiaries to differ
materially from those expressed or implied by such forward-looking
statements.

    All statements, other than the statements of historical fact, are
statements that may be deemed forward-looking statements, including
any projections of earnings, revenues, or other financial matters; any
statements of the plans, strategies, and objectives of management for
future operations; any statements concerning formation of industry
relationships, growth of product markets or sales, or consumer
and market acceptance of force feedback products in general; proposed
products or services; any statements regarding future economic
conditions or performance; statements of belief; and any statement or
assumptions underlying any of the foregoing. Immersion's actual
results might differ materially from those stated or implied by such
forward-looking statements due to risks and uncertainties associated
with our business which include, but are not limited to, delay in or
failure to achieve commercial demand for our products or a delay in or
failure to achieve the acceptance of force feedback as a critical user
experience.

    For a more detailed discussion of these factors, and other factors
that could cause actual results to vary materially, interested parties
should review the risk factors listed in our most current Form 10-Q,
which is on file with the U.S. Securities and Exchange Commission. The
forward-looking statements in this press release reflect our beliefs
and predictions as of the date of this release. We disclaim any
obligation to update these forward-looking statements as a result of
financial, business, or any other developments occurring after the
date of this release.

    Immersion, the Immersion logo, and TouchSense are trademarks of
Immersion Corporation in the United States and other countries. All
other trademarks are the property of their respective owners.

    CONTACT: A&R Edelman
             Alexandra Skillman, +1-650-762-2842
             askillman@ar-edelman.com